Elevance Health, Inc. (NYSE:ELV) is identified as the 18th pick on a list of Goldman Sachs' top fund manager stock picks, specifically among stocks where large-cap, growth, and value mutual fund managers hold overweight positions relative to benchmarks. The article highlights that ELV was included in this ranking based on data from Q2 2024, positioning it as a notable holding for institutional investors despite the broader market focus on artificial intelligence. The company is described as a diversified American healthcare services provider with a significant commercial market share of 12% and a large customer base of 47.5 million members. Fund manager Artisan Partners noted in its Q2 2024 investor letter that Elevance shares rose 5% during the quarter, driven by strong profit growth in its Carelon Services business and successful navigation of Medicaid redetermination challenges. Analysts view ELV as an attractive investment proposition trading at 13X earnings with expectations for long-term earnings growth exceeding 12%. However, the article notes that the stock remains vulnerable to government regulations affecting fee structures and membership numbers, citing an 8% decline in shares during 2023 due to drops in Medicaid memberships. The company is also actively working with a private equity firm to expand its presence in the primary care market.